Question 1

Does DME Capital Management own TEVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, DME Capital Management holds 2,886,059 shares of TEVA (Teva Pharmaceutical Industries), worth $97.8M.

Question 2

How many shares of TEVA does DME Capital Management own?

Accepted Answer

As of its Q2 2026 13F, DME Capital Management holds 2,886,059 shares of TEVA (Teva Pharmaceutical Industries).

Question 3

What is DME Capital Management's TEVA position worth?

Accepted Answer

As of its Q2 2026 13F, DME Capital Management's TEVA position is worth $97.8M.

Question 4

Is DME Capital Management buying or selling TEVA?

Accepted Answer

In Q2 2026, DME Capital Management reduced its TEVA position by 24,670 shares (-0.9%).

Question 5

When did DME Capital Management first buy TEVA?

Accepted Answer

DME Capital Management already held TEVA in its Q1 2024 13F, the earliest on record, and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	2.9M	-0.8%	$97.8M	2.5%	$33.88	0
2026-Q1	Decreased	2.9M	-4.8%	$87.7M	2.7%	$30.12	0
2025-Q4	Decreased	3.1M	-19.1%	$95.5M	3.4%	$31.21	0
2025-Q3	Unchanged	3.8M	0.0%	$76.3M	3.0%	$20.20	0
2025-Q2	Increased	3.8M	+565.0%	$63.3M	2.7%	$16.76	83
2025-Q1	Increased	568,200	+21.3%	$8.7M	0.4%	$15.37	40
2024-Q4	Increased	468,550	+44.2%	$10.3M	0.5%	$22.04	54
2024-Q3	Unchanged	324,850	0.0%	$5.9M	0.2%	$18.02	0